参考文献/References:
[1]Shih B, Bayat A. Genetics of keloid scarring. Arch Dermatol Res,2010,302(5):319-339.
[2]Huang da W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res,2009,37(1):1-13.
[3]Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc,2009,4(1):44-57.
[4]Szklarczyk D, Franceschini A, Kuhn M, et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res,2011,39(Database issue):D561- D568.
[5]Nassiri M, WooleryLloyd H, Ramos S, et al. Gene expression profiling reveals alteration of caspase 6 and 14 transcripts in normal skin of keloidprone patients. Arch Dermatol Res,2009,301(2):183-188.
[6]Smith JC, Boone BE, Opalenik SR, et al. Gene profiling of keloid fibroblasts shows altered expression in multiple fibrosisassociated pathways. J Invest Dermatol,2008,128(5):1298-1310.
[7]Seifert O, Bayat A, Geffers R, et al. Identification of unique gene expression patterns within different lesional sites of keloids. Wound Repair Regen, 2008, 16(2):254-265.
[8]Satish L, LyonsWeiler J, Hebda PA, et al. Gene expression patterns in isolated keloid fibroblasts. Wound Repair Regen,2006,14(4):463-470.
[9]胡振富,高建华,李薇,等.瘢痕疙瘩的差异表达基因谱研究.南方医科大学学报, 2006,26(3):308-312.
[10]Naitoh M, Kubota H, Ikeda M, et al. Gene expression in human keloids is altered from dermal to chondrocytic and osteogenic lineage. Genes Cells,2005,10(11):1081-1091.
[11]Na GY, Seo SK, Lee SJ, et al. Upregulation of the NNP1 (novel nuclear protein1, D21S2056E) gene in keloid tissue determined by cDNA microarray and in situ hybridization. Br J Dermatol,2004,151(6):1143-1149.
[12]Chen W, Fu X, Sun X, et al. Analysis of differentially expressed genes in keloids and normal skin with cDNA microarray. J Surg Res,2003,113(2):208-216.
[13]Swanson DR. Fish oil, Raynaud’s syndrome, and undiscovered public knowledge. Perspect Biol Med,1986,30(1):7-18.
[14]Cabodi S, del Pilar CamachoLeal M, Di Stefano P, et al. Integrin signaling adaptors: not only figurants in the cancer story. Nat Rev Cancer, 2010, 10(12):858-870.
[15]刘旺,蒋游晖,李友良,等.瘢痕疙瘩成纤维细胞p53基因突变的研究.中华烧伤杂志,2004,20(2): 85-87.
[16]刘永波,高建华,段红杰,等.瘢痕疙瘩p53基因突变高发区基因结构的研究.中华整形外科杂志,2003,19(4):258-260.
[17]段红杰,高建华,沈光裕.瘢痕疙瘩周围皮肤成纤维细胞周期分析及p53基因突变检测.中华整形外科杂志,2003,19(2):95-97.
[18]Saed GM, Ladin D, Olson J, et al. Analysis of p53 gene mutations in keloids using polymerase chain reactionbased singlestrand conformational polymorphism and DNA sequencing. Arch Dermatol,1998,134(8):963-967.
[19]Strano S, Dell′Orso S, Mongiovi AM, et al. Mutant p53 proteins: between loss and gain of function. Head Neck, 2007, 29(5):488-496.
[20]Pistritto G, Jost M, Srinivasula SM, et al. Expression and transcriptional regulation of caspase14 in simple and complex epithelia. Cell Death Differ,2002,9(9):995-1006.
[21]Russell SB, Trupin KM, RodríguezEaton S, et al. Reduced growthfactor requirement of keloidderived fibroblasts may account for tumor growth. Proc Natl Acad Sci U S A,1988,85(2):587-591.
[22]Luo S, Benathan M, Raffoul W, et al. Abnormal balance between proliferation and apoptotic cell death in fibroblasts derived from keloid lesions. Plast Reconstr Surg,2001,107(1):87-96.
[23]James WD, Besanceney CD, Odom RB. The ultrastructure of a keloid. J Am Acad Dermatol,1980,3(1):50-57.
[24]Ehrlich HP, Desmoulière A, Diegelmann RF, et al. Morphological and immunochemical differences between keloid and hypertrophic scar. Am J Pathol, 1994,145(1):105-113.
[25]Chipev CC, Simman R, Hatch G, et al. Myofibroblast phenotype and apoptosis in keloid and palmar fibroblasts in vitro. Cell Death Differ,2000,7(2):166-176.